Glucagon-like peptide-1 analog: Difference between revisions
Jump to navigation
Jump to search
(New page: '''Glucagon-like peptide-1 analog'''s are a new class of drug for treatment of type 2 diabetes.<ref>http://www.medscape.com/viewarticle/578304 "Glucagon-like Peptide-1 Analogs ...) |
No edit summary |
||
| Line 5: | Line 5: | ||
Licenced : [[exenatide]] (2005) | Licenced : [[exenatide]] (2005) | ||
Under investigation : | Under investigation : | ||
* albiglutide | |||
* taspoglutide | |||
==References== | ==References== | ||
Revision as of 23:13, 6 March 2009
Glucagon-like peptide-1 analogs are a new class of drug for treatment of type 2 diabetes.[1]
One of their advantages is that they have a lower risk of causing hypoglycemia.
Licenced : exenatide (2005)
Under investigation :
- albiglutide
- taspoglutide
References
- ↑ http://www.medscape.com/viewarticle/578304 "Glucagon-like Peptide-1 Analogs Other Than Exenatide"